http://www.x4pharma.com
X4 Pharmaceuticals, Inc. Company Intro
Our grit drives solutions for patients. Every day, we strive to advance our pipeline of innovative medicines to treat rare diseases. By targeting the CXCR4 pathway, our novel medicines are designed to restore healthy immunity in patients with rare diseases.
Industry
Healthcare
X4 Pharmaceuticals, Inc. Headquaters
955 Massachusetts Avenue
Cambridge,02139
United States
X4 Pharmaceuticals, Inc. Share price
14 Sep 2022 10:37 GMT
$1.1500
0.03 (2.68 %)
X4 Pharmaceuticals, Inc. Market cap
$31.503 M
WMC RANKING
2022
X4 Pharmaceuticals, Inc. # 226
BiotechnologyLatest X4 Pharmaceuticals, Inc. News
29 Nov 2022
X4 Pharmaceuticals Announces Positive Top-Line Results ...
X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company leading the discovery and development of novel therapies for people with diseases of the...
29 Nov 2022
X4 PHARMACEUTICALS, INC : Regulation FD Disclosure ...
On November 29, 2022 , X4 Pharmaceuticals, Inc. (the "Company") issued a press release announcing data from its Phase 3 clinical trial ("4WHIM") evaluating...
24 Nov 2022
X4 Pharmaceuticals Inc. (XFOR): Don't disregard this ominous ...
For the readers interested in the stock health of X4 Pharmaceuticals Inc. (XFOR). It is currently valued at $1.73. When the transactions were called off in...
WMC Market Score
WMC Market to Revenue Score
X4 Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| X4 Pharmaceuticals, Inc. | USD | $0 | $67,229 | $-77,908 | $315M | 226 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total X4 Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| X4 Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 43.17 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
